Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05928351
Other study ID # 2023/605
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date December 1, 2023

Study information

Verified date January 2024
Source Ahi Evran University Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of Pain Neuroscience Education (PNE) is to explain to patients the biological and physiological processes involved in a pain experience and, more importantly, defocus the issues associated with the anatomical structures. PNE provides compelling evidence in reducing pain, disability, pain catastrophization, and limited physical movement in musculoskeletal problems. Knee osteoarthritis (KOA) is a very common painful musculoskeletal problem, especially in people over 50 years old, and lead to decrease in knee range of motion. Despite costly arthroscopic surgeries and long-term physiotherapy treatments, poor outcomes are common. The lack of satisfactory results suggests that some practices should be revised. Although PNE could be useful as an intervention, to our knowledge, there is no randomized controlled trial in the literature investigating the effects of PNE in patients with a KOA. Therefore, we aimed to examine the effectiveness of PNE on clinical outcomes in patients with KOA.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 1, 2023
Est. primary completion date November 1, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Having a body mass index between 19-40 kg/m2, - Having had a unilateral TKA, - Knee pain score to be 4 and above daily according to the visual analog scale, - Ability to read, speak and understand Turkish. Exclusion Criteria: - Prosthesis disorders requiring re-surgery, - Having visual, auditory and cognitive impairment, - Secondary TKA such as rheumatoid arthritis, - Acute pain, - Pregnancy, drug and alcohol use, - Having bilateral TKA, - Not volunteering to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pain Neuroscience Education
The experimental group will follow a PNE protocol based on previous procedure for 6 weeks in addition to the standard physiotherapy program (SPP) in postoperative period. Each PNE session will take 45-60 min. PNE will be conducted in line with international guidelines and covered the neurophysiology of pain, transition from acute to chronic pain, and the nervous system ability to modulate the pain experience.
Standard Physiotherapy Program (SPP)
The control group will follow a SPP. The 45-minute-long treatment sessions will be held 5 days per week. The treatment program will be organized in 3 periods as 0-2 weeks, 3-4 weeks and 5-6 weeks. The overall treatment program will include scar massage, patellar mobilization, coldpack, ankle pump, quadriceps and hamstring strengthening, hip range of motion, hip strengthening exercises, squat, ascending and descending stairs, walking training. All exercises will be 10 repetitions x 2 sets.

Locations

Country Name City State
Turkey Ahi Evran University Kirsehir Central

Sponsors (1)

Lead Sponsor Collaborator
Ahi Evran University Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Louw A PT, PhD, Zimney K PT, DPT, Reed J PT, DPT, Landers M PT, DPT, PhD, Puentedura EJ PT, DPT, PhD. Immediate preoperative outcomes of pain neuroscience education for patients undergoing total knee arthroplasty: A case series. Physiother Theory Pract. 2019 Jun;35(6):543-553. doi: 10.1080/09593985.2018.1455120. Epub 2018 Mar 28. — View Citation

Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain severity Visual Analogue Scale (0-10, higher means worse) Baseline
Primary Pain severity change is being assessed Visual Analogue Scale (0-10, higher means worse) 6 week
Primary Pain and Function Knee Injury and Osteoarthritis Outcome Score (0-100, higher means better) Baseline
Primary Pain and Function change are being assessed Knee Injury and Osteoarthritis Outcome Score (0-100, higher means better) 6 week
Primary Pain and Function Western Ontario and McMaster Universities Arthritis Index (0-96, higher means worse) Baseline
Primary Pain and Function change are being assessed Western Ontario and McMaster Universities Arthritis Index (0-96, higher means worse) 6 week
Secondary Pain Catastrophizing Pain Catastrophizing Scale (0-52, higher means worse) Baseline
Secondary Pain Catastrophizing change is being assessed Pain Catastrophizing Scale (0-52, higher means worse) 6 week
Secondary Kinesiophobia Tampa Scale of Kinesiophobia (17-68, higher means worse) Baseline
Secondary Kinesiophobia change is being assessed Tampa Scale of Kinesiophobia (17-68, higher means worse) 6 week
Secondary Level of quality of life Short Form-12 (0-100, higher means better) Baseline
Secondary Level of quality of life change is being assessed Short Form-12 (0-100, higher means better) 6 week
Secondary Anxiety and Depression Hospital Anxiety Depression Scale (0-21, higher means worse) Baseline
Secondary Anxiety and Depression change is being assessed Hospital Anxiety Depression Scale (0-21, higher means worse) 6 week
Secondary Physical Function 40 meter walking test (in seconds, less is better) Baseline
Secondary Physical Function change is being assessed 40 meter walking test (in seconds, less is better) 6 week
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Not yet recruiting NCT02865174 - Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty Phase 4
Terminated NCT02615522 - Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration